• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about CANF

Recent news which mentions CANF

< Previous 1 2 Next >
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After
July 11, 2022
Tickers BIOVF CANF IBB INVA
Tags Penny Stocks PLRX COVID/19 Vaccine
From Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
July 01, 2022
Tickers ADSE ADTX AEMD AEZS
Tags AGRX Penny Stocks Pre/Market Outlook
From Benzinga
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
June 30, 2022
Tickers ADAG ADTX AEMD AEZS
Tags ENDP EVFM RPID
From Benzinga
Aspen Aerogels And 28 Stocks Moving Premarket
June 30, 2022
Tickers ADAG AGRX AIM AKBA
Tags Information Technology BBI TWOU
From Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
June 30, 2022
Tickers ADTH ADTX AEZS AGEN
Tags VEDU CUK AEZS
From Benzinga
The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data
June 29, 2022
Tickers ALXO BMY CANF ETNB
Tags OYST IBB Health Care
From Benzinga
Can-Fite BioPharma Shares Jump After Piclidenoson Data In Psoriasis Trial
June 29, 2022
Tickers AMGN CANF
Tags Briefs Health Care Trading Ideas
From Benzinga
Can Fite Biofarma: Q1 Earnings Insights
May 26, 2022
Tickers CANF
Tags Earnings Market News CANF
From Benzinga
Can-Fite Q1 Revenue Increases 38.5%, Phase III Psoriasis Treatment Study Results Expected In Q2
May 26, 2022
Tickers CANF
Tags Market News Dr/ Pnina Fishman Earnings
From Benzinga
Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?
April 12, 2022
Tickers ABBV AMGN CANF NVS
Tags ABBV Market News AMGN
From Benzinga
Can-Fite Reports Revenue Growth In 2021, Provides Clinical Update
March 24, 2022
Tickers CANF
Tags CANF Penny Stocks Market News
From Benzinga
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
March 24, 2022
Tickers AMGN CANF NVS
Tags Market News Health Care AMGN
From Benzinga
Can-Fite To Reveal Findings In Treatment Of Liver Cancer And Fibrosis With Cannabinoids At CannX
March 11, 2022
Tickers CANF
Tags Benzinga News Cannabis
From Benzinga
Can-Fite BioPharma Flags Delay In Piclidenoson Data Readout From Psoriasis Study
March 08, 2022
Tickers AMGN CANF
Tags Psoriasis Briefs Health Care
From Benzinga
CANF: Beginning to Flex Its Muscles; Initiating With OUTPERFORM Rating, $6.00 Price Target
February 23, 2022
Tickers CANF
Tags Market News CANF Can/Fite
From Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
February 03, 2022
Tickers ABBV AMGN BMY CANF
Tags ABBV BMY Can/Fite BioPharma Ltd/
From Benzinga
A New Oral Therapy for Psoriasis Could Be Coming Soon
January 24, 2022
Tickers ABBV AMGN CANF NVS
Tags Benzinga Partner Content Can/Fite BioPharma Ltd/
From Benzinga
Can Fite's Piclidenoson Destroys Pathological Skin Cells, Lab Study Shows
January 13, 2022
Tickers CANF
Tags Trading Ideas Benzinga Biotech
From Benzinga
The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
January 13, 2022
Tickers ADAG ADGI AZN BMY
Tags NRXP IBB GRTS
From Benzinga
PRIOR TO PHASE III PSORIASIS DATA RELEASE CAN FITE REPORTS THAT PICLIDENOSON DESTROYS PATHOLOGICAL SKIN CELLS IN VITRO
January 13, 2022
Tickers CANF
Tags Benzinga Press Releases Partner Content
From Benzinga
Can-Fite to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference
January 10, 2022
Tickers CANF CFBI
Tags CANF Penny Stocks Market News
From Benzinga
CAN-FITE ISSUES LETTER TO SHAREHOLDERS
January 05, 2022
Tickers CANF
Tags Benzinga Can/Fite BioPharma Ltd/ Press Releases
From Benzinga
FOLLOWING COMPLETE CLEARANCE OF CANCER LESIONS IN ADVANCED LIVER CANCER PATIENT, CAN-FITE IS FILING PATENT APPLICATIONS FOR THE TREATMENT OF VARIOUS ADVANCED SOLID TUMORS
January 03, 2022
Tickers CANF
Tags General Biotech Benzinga
From Benzinga
45 Biggest Movers From Yesterday
December 30, 2021
Tickers ADTH AEY ARHS ASTR
Tags AEY CALM DNAY
From Benzinga
26 Stocks Moving In Wednesday's Mid-Day Session
December 29, 2021
Tickers AUVI BFRI CALM CALX
Tags Trading Ideas Small Cap BFRI
From Benzinga
CANF Stock: The Cancer-Fighting News Sending Can-Fite Higher Today
December 29, 2021
Tickers CANF
Tags NYSEMKT:CANF Today's Market CANF
From InvestorPlace
55 Biggest Movers From Yesterday
December 22, 2021
Tickers ACAD AEHR ALDX AMAM
Tags JAKK BFRI PPSI
From Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
December 21, 2021
Tickers ACAD AERC ALDX AQST
Tags DTSS ZGN Penny Stocks
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 21, 2021
Tickers ALDX AQST ARDS BFRI
Tags MTC GNFT ARDS
From InvestorPlace
26 Stocks Moving in Tuesday's Pre-Market Session
December 21, 2021
Tickers ADGI ALDX AQST ARDS
Tags ADGI GNFT Markets
From Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap